Showing results (111-120 of 355) with videos related to
Sort By:
Pageof 36
Expert Opinion on Drug Metabolism & Toxicology|December 16, 2014
Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistanceAnna Wojtuszkiewicz, Yehuda G Assaraf, Marielle J P Maas, et al.Journal of Cardiovascular Pharmacology|October 10, 2017
Folic Acid Impairs the Uptake of 5-Methyltetrahydrofolate in Human Umbilical Vascular Endothelial CellsDesiree Smith, Jacqueline Hornstra, Monica Rocha, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 18, 2020
The role of alternative splicing in cancer: From oncogenesis to drug resistanceRocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G Assaraf, et al.Medicine and Science in Sports and Exercise|April 20, 2011
Match-related fatigue in soccer playersErmanno Rampinini, Andrea Bosio, Ivan Ferraresi, et al.Intensive Care Medicine|January 30, 2017
Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failureAndrea Morelli, Lorenzo Del Sorbo, Antonio Pesenti, et al.BMC Infectious Diseases|September 3, 2014
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infectionSimone Giuliano, Maurizio Guastalegname, Miryam Jenco, et al.Shock (Augusta, Ga.)|February 25, 2017
Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock: A Randomized Controlled Pilot StudyZied Hajjej, Bilel Meddeb, Walid Sellami, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|July 18, 2008
In vivo effects of modification of hydroxyapatite/collagen composites with and without chondroitin sulphate on bone remodeling in the sheep tibiaWolfgang Schneiders, Antje Reinstorf, Achim Biewener, et al.Cancer Metastasis Reviews|October 27, 2017
(Immuno)proteasomes as therapeutic target in acute leukemiaJacqueline Cloos, Margot Sf Roeten, Niels E Franke, et al.Cancer Drug Resistance (Alhambra, Calif.)|June 5, 2024
Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cellsLeonie De Wilt, Bartosz Kamil Sobocki, Gerrit Jansen, et al.Pageof 36